Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare.
BMJ Open
; 11(3): e043666, 2021 03 30.
Article
in En
| MEDLINE
| ID: mdl-33785490
Full text:
1
Database:
MEDLINE
Main subject:
Psoriasis
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
BMJ Open
Year:
2021
Type:
Article
Affiliation country:
Malaysia